GB9818110D0
(en)
|
1998-08-19 |
1998-10-14 |
Weston Medical Ltd |
Needleless injectors and other devices
|
US6264629B1
(en)
|
1998-11-18 |
2001-07-24 |
Bioject, Inc. |
Single-use needle-less hypodermic jet injection apparatus and method
|
US6383168B1
(en)
|
1998-12-08 |
2002-05-07 |
Bioject Medical Technologies Inc. |
Needleless syringe with prefilled cartridge
|
US6132395A
(en)
*
|
1998-12-08 |
2000-10-17 |
Bioject, Inc. |
Needleless syringe with prefilled cartridge
|
US7192713B1
(en)
|
1999-05-18 |
2007-03-20 |
President And Fellows Of Harvard College |
Stabilized compounds having secondary structure motifs
|
US7074210B2
(en)
*
|
1999-10-11 |
2006-07-11 |
Felton International, Inc. |
Universal protector cap with auto-disable features for needle-free injectors
|
US20020193740A1
(en)
|
1999-10-14 |
2002-12-19 |
Alchas Paul G. |
Method of intradermally injecting substances
|
US6494865B1
(en)
|
1999-10-14 |
2002-12-17 |
Becton Dickinson And Company |
Intradermal delivery device including a needle assembly
|
US6569123B2
(en)
|
1999-10-14 |
2003-05-27 |
Becton, Dickinson And Company |
Prefillable intradermal injector
|
US6569143B2
(en)
|
1999-10-14 |
2003-05-27 |
Becton, Dickinson And Company |
Method of intradermally injecting substances
|
US6776776B2
(en)
|
1999-10-14 |
2004-08-17 |
Becton, Dickinson And Company |
Prefillable intradermal delivery device
|
US6770054B1
(en)
|
1999-11-23 |
2004-08-03 |
Felton International, Inc. |
Injector assembly with driving means and locking means
|
US7887506B1
(en)
|
1999-11-23 |
2011-02-15 |
Pulse Needlefree Systems, Inc. |
Safety mechanism to prevent accidental patient injection and methods of same
|
US7029457B2
(en)
*
|
1999-11-23 |
2006-04-18 |
Felton International, Inc. |
Jet injector with hand piece
|
US6558348B2
(en)
|
2000-04-07 |
2003-05-06 |
Equidyne Systems, Inc. |
Low cost disposable needleless injector system for variable and fixed dose applications
|
JP2003533289A
(ja)
|
2000-05-16 |
2003-11-11 |
ウェストン、メディカル、リミテッド |
薬剤再構成用液体移送装置又は液体薬剤移送
|
GB0022742D0
(en)
|
2000-09-15 |
2000-11-01 |
Smithkline Beecham Biolog |
Vaccine
|
AU2002254901A1
(en)
|
2001-02-23 |
2002-10-03 |
Smithkline Beecham Biologicals S.A. |
Influenza vaccine formulations for intradermal delivery
|
JP2002263106A
(ja)
*
|
2001-03-12 |
2002-09-17 |
Olympus Optical Co Ltd |
光プローブ装置
|
WO2002074406A1
(en)
|
2001-03-14 |
2002-09-26 |
Penjet Corporation |
System and method for removing dissolved gas from a solution
|
GB0109297D0
(en)
|
2001-04-12 |
2001-05-30 |
Glaxosmithkline Biolog Sa |
Vaccine
|
US6613010B2
(en)
|
2001-04-13 |
2003-09-02 |
Penjet Corporation |
Modular gas-pressured needle-less injector
|
US6755220B2
(en)
|
2001-04-27 |
2004-06-29 |
Penjet Corporation |
Method and apparatus for filling or refilling a needle-less injector
|
US20100221284A1
(en)
|
2001-05-30 |
2010-09-02 |
Saech-Sisches Serumwerk Dresden |
Novel vaccine composition
|
TWI228420B
(en)
|
2001-05-30 |
2005-03-01 |
Smithkline Beecham Pharma Gmbh |
Novel vaccine composition
|
US6824526B2
(en)
|
2001-10-22 |
2004-11-30 |
Penjet Corporation |
Engine and diffuser for use with a needle-less injector
|
GB0125506D0
(en)
|
2001-10-24 |
2001-12-12 |
Weston Medical Ltd |
Needle free injection method and apparatus
|
GB0206560D0
(en)
|
2002-03-20 |
2002-05-01 |
Glaxo Group Ltd |
Novel device
|
MY139059A
(en)
|
2002-06-24 |
2009-08-28 |
Alza Corp |
Reusable, spring driven autoinjector
|
MXPA05002072A
(es)
|
2002-08-26 |
2005-06-08 |
Penjet Corp |
Aparato para inyeccion sin aguja de fluido desgasificado.
|
ES2427641T3
(es)
|
2003-05-22 |
2013-10-31 |
Ibio, Inc. |
Molécula vehículo recombinante para la expresión, el suministro y la purificación de polipéptidos diana
|
AU2003270473A1
(en)
|
2003-09-09 |
2005-04-27 |
University Of Florida |
Desferrithiocin derivatives and their use as iron chelators
|
DE10342058B4
(de)
*
|
2003-09-11 |
2007-10-25 |
Tecpharma Licensing Ag |
Verabreichungsvorrichtung für ein injizierbares Produkt mit einer Auslösesicherung
|
CN1906209A
(zh)
|
2003-11-05 |
2007-01-31 |
达纳-法伯癌症研究所股份有限公司 |
稳定的α螺旋肽及其用途
|
WO2005056077A2
(en)
|
2003-12-05 |
2005-06-23 |
Aradigm Corporation |
A device for readying a needle free injector for delivery
|
US7717874B2
(en)
|
2004-05-28 |
2010-05-18 |
Bioject, Inc. |
Needle-free injection system
|
EP1781180A2
(en)
*
|
2004-07-08 |
2007-05-09 |
CliniWave, Inc. |
Rolling tube apparatus and method for treating a wound
|
KR101505496B1
(ko)
|
2004-09-22 |
2015-03-25 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
스태필로코쿠스에 대한 예방접종에 사용하기 위한 면역원성 조성물
|
WO2007001448A2
(en)
|
2004-11-04 |
2007-01-04 |
Massachusetts Institute Of Technology |
Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
|
EP2532378B1
(en)
|
2004-12-01 |
2016-04-27 |
AcuShot, Inc. |
Needle-free injector
|
AU2006226458B2
(en)
|
2005-03-23 |
2012-08-30 |
Glaxosmithkline Biologicals S.A. |
Novel composition
|
CN101189216B
(zh)
|
2005-04-04 |
2011-10-19 |
佛罗里达大学研究基金会 |
Desferrithiocin聚醚类似物
|
CA2616859C
(en)
|
2005-08-03 |
2015-04-14 |
Fraunhofer Usa, Inc. |
Compositions and methods for production of immunoglobulins
|
US20070055200A1
(en)
|
2005-08-10 |
2007-03-08 |
Gilbert Scott J |
Needle-free jet injection drug delivery device
|
TWI457133B
(zh)
|
2005-12-13 |
2014-10-21 |
Glaxosmithkline Biolog Sa |
新穎組合物
|
WO2007070682A2
(en)
|
2005-12-15 |
2007-06-21 |
Massachusetts Institute Of Technology |
System for screening particles
|
GB0607088D0
(en)
|
2006-04-07 |
2006-05-17 |
Glaxosmithkline Biolog Sa |
Vaccine
|
EP3020411A1
(en)
|
2005-12-22 |
2016-05-18 |
GlaxoSmithKline Biologicals s.a. |
Vaccine
|
EP1984405A4
(en)
|
2006-02-13 |
2010-06-30 |
Fraunhofer Usa Inc |
INFLUENZA ANTIGENS, VACCINE COMPOSITIONS AND ASSOCIATED METHODS
|
CA2681668C
(en)
|
2006-03-23 |
2014-04-01 |
Michael S. Singer |
Compositions comprising prostaglandin f2-alpha analogs and methods for reducing body fat
|
JP2009531387A
(ja)
|
2006-03-30 |
2009-09-03 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
免疫原性組成物
|
CA2648099C
(en)
|
2006-03-31 |
2012-05-29 |
The Brigham And Women's Hospital, Inc |
System for targeted delivery of therapeutic agents
|
EP2019691B1
(en)
|
2006-05-15 |
2020-08-12 |
Massachusetts Institute of Technology |
Polymers for functional particles
|
AU2007256780B2
(en)
|
2006-06-02 |
2013-08-29 |
President And Fellows Of Harvard College |
Protein surface remodeling
|
KR101428500B1
(ko)
*
|
2006-06-13 |
2014-08-11 |
노드슨 코포레이션 |
액체 투여 주사기
|
WO2007150030A2
(en)
|
2006-06-23 |
2007-12-27 |
Massachusetts Institute Of Technology |
Microfluidic synthesis of organic nanoparticles
|
DK2043682T3
(da)
|
2006-07-17 |
2014-06-02 |
Glaxosmithkline Biolog Sa |
Influenzavaccine
|
WO2008021367A2
(en)
|
2006-08-11 |
2008-02-21 |
President And Fellows Of Harvard College |
Moenomycin biosynthesis-related compositions and methods of use thereof
|
US7547293B2
(en)
|
2006-10-06 |
2009-06-16 |
Bioject, Inc. |
Triggering mechanism for needle-free injector
|
JO3598B1
(ar)
|
2006-10-10 |
2020-07-05 |
Infinity Discovery Inc |
الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
|
EP2086582B1
(en)
|
2006-10-12 |
2012-11-14 |
GlaxoSmithKline Biologicals s.a. |
Vaccine comprising an oil in water emulsion adjuvant
|
US20100183667A1
(en)
|
2006-10-12 |
2010-07-22 |
Glaxo Smithkline Biologicals S.A. |
Vaccine Comprising an Oil in Water Emulsion Adjuvant
|
WO2008070538A2
(en)
|
2006-12-01 |
2008-06-12 |
Anterios, Inc. |
Micellar nanoparticles comprising botulinum toxin
|
EP2474526A3
(en)
|
2006-12-26 |
2012-07-25 |
Lantheus Medical Imaging, Inc. |
Ligands for imaging cardiac innervation
|
DK2118123T3
(en)
|
2007-01-31 |
2016-01-25 |
Dana Farber Cancer Inst Inc |
Stabilized p53 peptides and uses thereof
|
US9217129B2
(en)
|
2007-02-09 |
2015-12-22 |
Massachusetts Institute Of Technology |
Oscillating cell culture bioreactor
|
WO2008103997A2
(en)
|
2007-02-23 |
2008-08-28 |
Bioject Inc. |
Needle-free injection devices and drug delivery systems therefor
|
AU2008229472B2
(en)
|
2007-03-15 |
2013-03-14 |
University Of Florida Research Foundation, Inc. |
Desferrithiocin polyether analogues
|
US7960139B2
(en)
|
2007-03-23 |
2011-06-14 |
Academia Sinica |
Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
|
ES2610531T3
(es)
|
2007-03-28 |
2017-04-28 |
President And Fellows Of Harvard College |
Polipéptidos cosidos
|
EP2144600A4
(en)
|
2007-04-04 |
2011-03-16 |
Massachusetts Inst Technology |
POLY (AMINIC ACID) TARGET MOLECULES
|
BRPI0810865A2
(pt)
|
2007-04-28 |
2017-05-09 |
Fraunhofer Usa Inc |
antígenos de tripanossoma, composições vacinais, e métodos relacionados
|
ES2354016T3
(es)
*
|
2007-05-14 |
2011-03-09 |
Shl Group Ab |
Dispositivo de administración.
|
WO2008156676A1
(en)
|
2007-06-15 |
2008-12-24 |
President And Fellows Of Harvard College |
Methods and compositions for detecting and modulating o-glycosylation
|
WO2009000825A2
(en)
|
2007-06-26 |
2008-12-31 |
Glaxosmithkline Biologicals S.A. |
Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
|
CA2692933C
(en)
|
2007-07-11 |
2016-10-18 |
Fraunhofer Usa, Inc. |
Yersinia pestis antigens, vaccine compositions, and related methods
|
US8604004B2
(en)
|
2007-10-04 |
2013-12-10 |
President And Fellows Of Harvard College |
Moenomycin analogs, methods of synthesis, and uses thereof
|
BRPI0817664A2
(pt)
|
2007-10-12 |
2015-03-24 |
Massachusetts Inst Technology |
Nanopartículas, método para preparar nanopartículas e método para tratar terapeuticamente ou profilaticamente um indivíduo
|
CA2711330A1
(en)
|
2008-01-03 |
2009-07-16 |
Massachusetts Institute Of Technology |
Decoy influenza therapies
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
EA201001479A1
(ru)
|
2008-04-16 |
2011-06-30 |
Глаксосмитклайн Байолоджикалс С.А. |
Вакцина
|
CN102014625A
(zh)
*
|
2008-04-28 |
2011-04-13 |
佐吉尼克斯股份有限公司 |
用于治疗偏头痛的新制剂
|
CN102076333A
(zh)
|
2008-06-26 |
2011-05-25 |
安特里奥公司 |
真皮递送
|
ES2442024T3
(es)
|
2008-07-15 |
2014-02-07 |
Academia Sinica |
Matrices de glucano sobre portaobjetos de vidrio revestidos con aluminio de tipo PTFE y métodos relacionados
|
EP2356139A4
(en)
|
2008-07-23 |
2013-01-09 |
Harvard College |
LIGATURE OF STAPLED POLYPEPTIDES
|
CA2737921C
(en)
|
2008-09-22 |
2019-01-15 |
Aileron Therapeutics, Inc. |
Methods for preparing purified alpha-helical peptidomimetic macrocycle compositions with low metal ppm levels
|
US8734803B2
(en)
|
2008-09-28 |
2014-05-27 |
Ibio Inc. |
Humanized neuraminidase antibody and methods of use thereof
|
US8591905B2
(en)
|
2008-10-12 |
2013-11-26 |
The Brigham And Women's Hospital, Inc. |
Nicotine immunonanotherapeutics
|
US8277812B2
(en)
|
2008-10-12 |
2012-10-02 |
Massachusetts Institute Of Technology |
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
|
US8343498B2
(en)
|
2008-10-12 |
2013-01-01 |
Massachusetts Institute Of Technology |
Adjuvant incorporation in immunonanotherapeutics
|
US8343497B2
(en)
|
2008-10-12 |
2013-01-01 |
The Brigham And Women's Hospital, Inc. |
Targeting of antigen presenting cells with immunonanotherapeutics
|
WO2010057197A1
(en)
|
2008-11-17 |
2010-05-20 |
The Regents Of The University Of Michigan |
Cancer vaccine compositions and methods of using the same
|
EP2376619A4
(en)
|
2008-12-15 |
2012-07-04 |
Greenlight Biosciences Inc |
METHODS FOR CONTROLLING FLOWS IN METABOLIC PATHWAYS
|
DE102008063517A1
(de)
*
|
2008-12-18 |
2010-07-01 |
Lts Lohmann Therapie-Systeme Ag |
Einmalinjektor mit einem biegeelastischen Gehäuse II
|
DE102008063519A1
(de)
*
|
2008-12-18 |
2010-07-01 |
Lts Lohmann Therapie-Systeme Ag |
Einmalinjektor mit einem biegeelastischen Metallgehäuse
|
CA2744088A1
(en)
|
2009-01-14 |
2010-07-22 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
JP2012525146A
(ja)
|
2009-04-28 |
2012-10-22 |
プレジデント アンド フェロウズ オブ ハーバード カレッジ |
細胞透過のための過剰に荷電されたタンパク質
|
WO2010141074A2
(en)
|
2009-06-01 |
2010-12-09 |
President And Fellows Of Harvard College |
O-glcnac transferase inhibitors and uses thereof
|
EP2453908B1
(en)
|
2009-07-13 |
2018-03-14 |
President and Fellows of Harvard College |
Bifunctional stapled polypeptides and uses thereof
|
GB0913681D0
(en)
|
2009-08-05 |
2009-09-16 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
US20130072439A1
(en)
|
2009-09-22 |
2013-03-21 |
Huw M. Nash |
Peptidomimetic macrocycles
|
CA2776144C
(en)
|
2009-09-29 |
2020-10-27 |
Fraunhofer Usa, Inc. |
Influenza hemagglutinin antibodies, compositions, and related methods
|
GB2477487A
(en)
*
|
2009-10-12 |
2011-08-10 |
Owen Mumford Ltd |
Injection device
|
US11377485B2
(en)
|
2009-12-02 |
2022-07-05 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
US10087236B2
(en)
|
2009-12-02 |
2018-10-02 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
GB0921295D0
(en)
*
|
2009-12-04 |
2010-01-20 |
Owen Mumford Ltd |
Injection appaeratus
|
CA2787940C
(en)
|
2010-01-27 |
2020-01-07 |
Massachusetts Institute Of Technology |
Engineered polypeptide agents for targeted broad spectrum influenza neutralization
|
EP4201402A1
(en)
|
2010-03-08 |
2023-06-28 |
Sloan-Kettering Institute For Cancer Research |
Cdc7 kinase inhibitors and uses thereof
|
GB201003920D0
(en)
|
2010-03-09 |
2010-04-21 |
Glaxosmithkline Biolog Sa |
Method of treatment
|
GB201003922D0
(en)
|
2010-03-09 |
2010-04-21 |
Glaxosmithkline Biolog Sa |
Conjugation process
|
US9102697B2
(en)
|
2010-03-22 |
2015-08-11 |
President And Fellows Of Harvard College |
Trioxacarcins and uses thereof
|
WO2011130332A1
(en)
|
2010-04-12 |
2011-10-20 |
Academia Sinica |
Glycan arrays for high throughput screening of viruses
|
US8450350B2
(en)
|
2010-05-05 |
2013-05-28 |
Infinity Pharmaceuticals, Inc. |
Triazoles as inhibitors of fatty acid synthase
|
EP3159331A1
(en)
|
2010-05-05 |
2017-04-26 |
Infinity Pharmaceuticals, Inc. |
Tetrazolones as inhibitors of fatty acid synthase
|
EP2566953B1
(en)
|
2010-05-07 |
2019-01-02 |
Greenlight Biosciences, Inc. |
Methods for control of flux in metabolic pathways through enzyme relocation
|
BR122020018194B1
(pt)
|
2010-05-11 |
2021-07-27 |
Lantheus Medical Imaging, Inc. |
Composições e métodos de síntese de agentes de imagiologia
|
JP6022442B2
(ja)
|
2010-05-14 |
2016-11-09 |
ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド |
男性用避妊組成物および使用方法
|
WO2011160042A2
(en)
|
2010-06-18 |
2011-12-22 |
Makoto Life Sciences, Inc. |
Prpk-tprkb modulators and uses thereof
|
EP3578205A1
(en)
|
2010-08-06 |
2019-12-11 |
ModernaTX, Inc. |
A pharmaceutical formulation comprising engineered nucleic acids and medical use thereof
|
ES2711526T3
(es)
|
2010-08-13 |
2019-05-06 |
Aileron Therapeutics Inc |
Macrociclos peptidomiméticos
|
JP6280367B2
(ja)
|
2010-08-31 |
2018-02-14 |
グリーンライト バイオサイエンシーズ インコーポレーテッドGreenlight Biosciences,Inc. |
プロテアーゼ操作を介した代謝経路におけるフラックスの制御のための方法
|
CA2810078A1
(en)
|
2010-09-15 |
2012-03-22 |
Zogenix, Inc. |
Needle-free injectors and design parameters thereof that optimize injection performance
|
US8802110B2
(en)
|
2010-09-21 |
2014-08-12 |
Massachusetts Institute Of Technology |
Influenza treatment and/or characterization, human-adapted HA polypeptides; vaccines
|
US8957026B2
(en)
|
2010-09-22 |
2015-02-17 |
President And Fellows Of Harvard College |
Beta-catenin targeting peptides and uses thereof
|
WO2012045082A2
(en)
|
2010-10-01 |
2012-04-05 |
Jason Schrum |
Engineered nucleic acids and methods of use thereof
|
AU2011312178B2
(en)
|
2010-10-04 |
2016-05-12 |
Massachusetts Institute Of Technology |
Hemagglutinin polypeptides, and reagents and methods relating thereto
|
EP2438945A1
(en)
*
|
2010-10-08 |
2012-04-11 |
Sanofi-Aventis Deutschland GmbH |
Reusable engine for an auto-injector
|
JP2013545749A
(ja)
|
2010-11-10 |
2013-12-26 |
インフィニティー ファーマシューティカルズ, インコーポレイテッド |
複素環化合物及びその使用
|
CA2822908A1
(en)
*
|
2011-01-10 |
2012-07-19 |
Zogenix, Inc. |
Improved needle free injectors
|
CA2824197C
(en)
|
2011-01-10 |
2020-02-25 |
Michael Martin |
Processes for preparing isoquinolinones and solid forms of isoquinolinones
|
ES2579990T3
(es)
|
2011-01-19 |
2016-08-18 |
Terakine Therapeutics, Inc. |
Métodos y composiciones para tratar el síndrome metabólico
|
JP2014503586A
(ja)
|
2011-01-24 |
2014-02-13 |
アンテリオス, インコーポレイテッド |
油組成物
|
DK2667854T3
(en)
|
2011-01-24 |
2019-04-23 |
Anterios Inc |
NANO PARTICLE FORMATIONS
|
US20120328701A1
(en)
|
2011-01-24 |
2012-12-27 |
Anterios, Inc. |
Nanoparticle compositions, formulations thereof, and uses therefor
|
JP5794786B2
(ja)
*
|
2011-02-04 |
2015-10-14 |
株式会社ダイセル |
無針注射器
|
EP3510998A1
(en)
|
2011-03-03 |
2019-07-17 |
Tersus Pharmaceuticals, LLC |
Compositions and methods comprising c16:1n7-palmitoleate
|
GB201103836D0
(en)
|
2011-03-07 |
2011-04-20 |
Glaxosmithkline Biolog Sa |
Conjugation process
|
US9193767B2
(en)
|
2011-03-30 |
2015-11-24 |
Brown University |
Enopeptins, uses thereof, and methods of synthesis thereto
|
AU2012236099A1
(en)
|
2011-03-31 |
2013-10-03 |
Moderna Therapeutics, Inc. |
Delivery and formulation of engineered nucleic acids
|
WO2012156391A1
(en)
|
2011-05-17 |
2012-11-22 |
Glaxosmithkline Biologicals S.A. |
Vaccine against streptococcus pneumoniae
|
AU2012272815B2
(en)
|
2011-06-22 |
2017-09-07 |
The General Hospital Corporation |
Treatment of proteinopathies
|
CA2842190A1
(en)
|
2011-07-19 |
2013-01-24 |
Infinity Pharmaceuticals Inc. |
Heterocyclic compounds and uses thereof
|
CN103930422A
(zh)
|
2011-07-19 |
2014-07-16 |
无限药品股份有限公司 |
杂环化合物及其用途
|
PL2734510T4
(pl)
|
2011-07-22 |
2019-05-31 |
Massachusetts Inst Technology |
Aktywatory deacetylaz histonowych klasy I (HDAC) i ich zastosowania
|
AR091790A1
(es)
|
2011-08-29 |
2015-03-04 |
Infinity Pharmaceuticals Inc |
Derivados de isoquinolin-1-ona y sus usos
|
BR112014005286B1
(pt)
|
2011-09-09 |
2022-08-23 |
Lantheus Medical Imaging, Inc |
Compostos de um primeiro e um segundo agente de imageamento para determinar incompatibilidade de inervação e perfusão na parte do indivíduo
|
SG2014014377A
(en)
|
2011-09-09 |
2014-05-29 |
Greenlight Biosciences Inc |
Cell-free preparation of carbapenems
|
EP2755693A4
(en)
|
2011-09-12 |
2015-05-20 |
Moderna Therapeutics Inc |
MODIFIED NUCLEIC ACIDS AND METHODS OF USE
|
WO2013049332A1
(en)
|
2011-09-29 |
2013-04-04 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of monoacylglycerol lipase and methods of their use
|
EP3682905B1
(en)
|
2011-10-03 |
2021-12-01 |
ModernaTX, Inc. |
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
|
RU2639523C2
(ru)
|
2011-10-18 |
2017-12-21 |
Эйлерон Терапьютикс, Инк. |
Пептидомиметические макроциклы и их применение
|
WO2013074986A1
(en)
|
2011-11-17 |
2013-05-23 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of c-jun-n-terminal kinase (jnk)
|
GB201120000D0
(en)
|
2011-11-20 |
2012-01-04 |
Glaxosmithkline Biolog Sa |
Vaccine
|
GB201119999D0
(en)
|
2011-11-20 |
2012-01-04 |
Glaxosmithkline Biolog Sa |
Vaccine
|
DK2791160T3
(da)
|
2011-12-16 |
2022-05-30 |
Modernatx Inc |
Modificerede mrna-sammensætninger
|
US8426471B1
(en)
|
2011-12-19 |
2013-04-23 |
Topokine Therapeutics, Inc. |
Methods and compositions for reducing body fat and adipocytes
|
JP6450192B2
(ja)
|
2012-02-15 |
2019-01-09 |
エイルロン セラピューティクス,インコーポレイテッド |
トリアゾール架橋した、およびチオエーテル架橋したペプチドミメティック大環状化合物
|
MX362492B
(es)
|
2012-02-15 |
2019-01-21 |
Aileron Therapeutics Inc |
Macrociclos peptidomiméticos.
|
WO2013151697A1
(en)
|
2012-04-06 |
2013-10-10 |
President And Fellows Of Harvard College |
Methods and compounds for identifying glycosyltransferase inhibitors
|
EP2834254A2
(en)
|
2012-04-06 |
2015-02-11 |
President and Fellows of Harvard College |
Moenomycin analogs, methods of synthesis, and uses thereof
|
EP2850090B1
(en)
|
2012-04-06 |
2018-10-03 |
President and Fellows of Harvard College |
Chemoenzymatic methods for synthesizing moenomycin analogs
|
US8940742B2
(en)
|
2012-04-10 |
2015-01-27 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
US10130714B2
(en)
|
2012-04-14 |
2018-11-20 |
Academia Sinica |
Enhanced anti-influenza agents conjugated with anti-inflammatory activity
|
EP2841098A4
(en)
|
2012-04-23 |
2016-03-02 |
Allertein Therapeutics Llc |
NANOPARTICLES FOR THE TREATMENT OF ALLERGIES
|
US20140142500A1
(en)
|
2012-04-23 |
2014-05-22 |
Zogenix, Inc. |
Piston closures for drug delivery capsules
|
CA2871160C
(en)
|
2012-05-10 |
2023-03-14 |
Massachusetts Institute Of Technology |
Agents for influenza neutralization
|
SG11201500573RA
(en)
|
2012-08-06 |
2015-02-27 |
Glaxosmithkline Biolog Sa |
Method for eliciting in infants an immune response against rsv and b. pertussis
|
US20140037680A1
(en)
|
2012-08-06 |
2014-02-06 |
Glaxosmithkline Biologicals, S.A. |
Novel method
|
AU2013203000B9
(en)
|
2012-08-10 |
2017-02-02 |
Lantheus Medical Imaging, Inc. |
Compositions, methods, and systems for the synthesis and use of imaging agents
|
AU2013306098A1
(en)
|
2012-08-18 |
2015-02-12 |
Academia Sinica |
Cell-permeable probes for identification and imaging of sialidases
|
WO2014033287A1
(de)
*
|
2012-08-30 |
2014-03-06 |
Lts Lohmann Therapie-Systeme Ag |
Testvorrichtung zur abgabe einer substanz in ein medium
|
WO2014052647A2
(en)
|
2012-09-26 |
2014-04-03 |
President And Fellows Of Harvard College |
Proline-locked stapled peptides and uses thereof
|
US20150225471A1
(en)
|
2012-10-01 |
2015-08-13 |
President And Fellows Of Harvard College |
Stabilized polypeptide insulin receptor modulators
|
PT2909204T
(pt)
|
2012-10-12 |
2019-03-21 |
Dana Farber Cancer Inst Inc |
Inibidores de gsk3 e métodos de utilização dos mesmos
|
EP2909194A1
(en)
|
2012-10-18 |
2015-08-26 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinase 7 (cdk7)
|
USRE48175E1
(en)
|
2012-10-19 |
2020-08-25 |
Dana-Farber Cancer Institute, Inc. |
Hydrophobically tagged small molecules as inducers of protein degradation
|
AU2013337388B2
(en)
|
2012-11-01 |
2018-08-02 |
Aileron Therapeutics, Inc. |
Disubstituted amino acids and methods of preparation and use thereof
|
AU2013337717B2
(en)
|
2012-11-01 |
2018-10-25 |
Infinity Pharmaceuticals, Inc. |
Treatment of cancers using PI3 kinase isoform modulators
|
WO2014071247A1
(en)
|
2012-11-02 |
2014-05-08 |
Dana-Farber Cancer Institute, Inc. |
Pyrrol-1 -yl benzoic acid derivates useful as myc inhibitors
|
US8778981B2
(en)
|
2012-11-21 |
2014-07-15 |
Topokine Therapeutics, Inc. |
Methods and compositions for locally increasing body fat
|
US9775915B2
(en)
|
2012-11-26 |
2017-10-03 |
President And Fellows Of Harvard College |
Trioxacarcins, trioxacarcin-antibody conjugates, and uses thereof
|
HRP20220607T1
(hr)
|
2012-11-26 |
2022-06-24 |
Modernatx, Inc. |
Terminalno modificirana rna
|
EP2742963A1
(en)
*
|
2012-12-17 |
2014-06-18 |
Sanofi-Aventis Deutschland GmbH |
Drug delivery device
|
US8993555B2
(en)
|
2012-12-21 |
2015-03-31 |
Epizyme, Inc. |
PRMT5 inhibitors and uses thereof
|
US9365555B2
(en)
|
2012-12-21 |
2016-06-14 |
Epizyme, Inc. |
PRMT5 inhibitors and uses thereof
|
US9908887B2
(en)
|
2012-12-21 |
2018-03-06 |
Epizyme, Inc. |
PRMT5 inhibitors and uses thereof
|
WO2014100730A1
(en)
|
2012-12-21 |
2014-06-26 |
Epizyme, Inc. |
Prmt5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereof
|
WO2014113089A2
(en)
|
2013-01-17 |
2014-07-24 |
Moderna Therapeutics, Inc. |
Signal-sensor polynucleotides for the alteration of cellular phenotypes
|
ES2959258T3
(es)
|
2013-02-07 |
2024-02-22 |
Childrens Medical Center |
Antígenos proteicos que proporcionan protección contra la colonización y/o la enfermedad neumocócicas
|
CA2898633C
(en)
|
2013-02-07 |
2021-07-13 |
Massachusetts Institute Of Technology |
Human adaptation of h5 influenza
|
CN109602692B
(zh)
|
2013-03-11 |
2022-11-04 |
度瑞公司 |
包含高粘度液体载体的可注射控制释放组合物
|
US20160024181A1
(en)
|
2013-03-13 |
2016-01-28 |
Moderna Therapeutics, Inc. |
Long-lived polynucleotide molecules
|
US10081654B2
(en)
|
2013-03-13 |
2018-09-25 |
President And Fellows Of Harvard College |
Stapled and stitched polypeptides and uses thereof
|
NZ629037A
(en)
|
2013-03-15 |
2017-04-28 |
Infinity Pharmaceuticals Inc |
Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
|
EP2981285B1
(en)
|
2013-04-03 |
2020-06-03 |
N-Fold Llc |
Novel nanoparticle compositions
|
CN111825733A
(zh)
|
2013-04-04 |
2020-10-27 |
哈佛大学的校长及成员们 |
大环内酯及其制备和使用方法
|
ES2774330T3
(es)
|
2013-04-09 |
2020-07-20 |
Massachusetts Inst Technology |
Polímero de suministro de fármaco y usos del mismo
|
WO2014179464A1
(en)
|
2013-04-30 |
2014-11-06 |
Massachusetts Institute Of Technology |
Human adaptation of h3 influenza
|
WO2014179562A1
(en)
|
2013-05-01 |
2014-11-06 |
Massachusetts Institute Of Technology |
1,3,5-triazinane-2,4,6-trione derivatives and uses thereof
|
NO2753788T3
(hu)
|
2013-05-10 |
2018-06-16 |
|
|
RU2019134551A
(ru)
|
2013-05-30 |
2019-11-22 |
Инфинити Фармасьютикалз, Инк. |
Лечение злокачественных опухолей с использованием модуляторов изоформ pi3-киназы
|
WO2014197723A2
(en)
|
2013-06-05 |
2014-12-11 |
Massachusetts Institute Of Technology |
Human adaptation of h7 ha
|
WO2014201127A2
(en)
|
2013-06-11 |
2014-12-18 |
Kala Pharmaceuticals, Inc. |
Urea derivatives and uses thereof
|
KR20160019547A
(ko)
|
2013-06-14 |
2016-02-19 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
안정화된 폴리펩티드 인슐린 수용체 조절제
|
US10086054B2
(en)
|
2013-06-26 |
2018-10-02 |
Academia Sinica |
RM2 antigens and use thereof
|
WO2014210564A1
(en)
|
2013-06-27 |
2014-12-31 |
Academia Sinica |
Glycan conjugates and use thereof
|
RU2016105108A
(ru)
|
2013-07-25 |
2017-08-30 |
Дана-Фарбер Кэнсер Инститьют, Инк. |
Ингибиторы факторов транскрипции и их применение
|
JP6483687B2
(ja)
|
2013-08-05 |
2019-03-13 |
グリーンライト バイオサイエンシーズ インコーポレーテッドGreenlight Biosciences,Inc. |
プロテアーゼ切断部位を有する操作されたタンパク質
|
SG11201600709TA
(en)
|
2013-08-05 |
2016-02-26 |
Glaxosmithkline Biolog Sa |
Combination immunogenic compositions
|
JP6486368B2
(ja)
|
2013-09-06 |
2019-03-20 |
アカデミア シニカAcademia Sinica |
改変されたグリコシル基を含む糖脂質を用いたヒトiNKT細胞の活性化
|
WO2015051241A1
(en)
|
2013-10-04 |
2015-04-09 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
MX2016004340A
(es)
|
2013-10-04 |
2016-08-08 |
Infinity Pharmaceuticals Inc |
Compuestos heterociclicos y usos de los mismos.
|
WO2015057894A1
(en)
|
2013-10-15 |
2015-04-23 |
Massachusetts Institute Of Technology |
Methods for treating polycystic kidney disease and polycystic liver disease
|
WO2015057958A2
(en)
|
2013-10-16 |
2015-04-23 |
Massachusetts Institute Of Technology |
Enterobactin conjugates and uses thereof
|
CN105849099B
(zh)
|
2013-10-18 |
2020-01-17 |
达纳-法伯癌症研究所股份有限公司 |
周期蛋白依赖性激酶7(cdk7)的多环抑制剂
|
WO2015061204A1
(en)
|
2013-10-21 |
2015-04-30 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
CA2928658A1
(en)
|
2013-11-01 |
2015-05-07 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
WO2015070020A2
(en)
|
2013-11-08 |
2015-05-14 |
Dana-Farber Cancer Institute, Inc. |
Combination therapy for cancer using bromodomain and extra-terminal (bet) protein inhibitors
|
EP3505521A1
(en)
|
2013-12-24 |
2019-07-03 |
President and Fellows of Harvard College |
Cortistatin analogues and syntheses and uses thereof
|
US9982041B2
(en)
|
2014-01-16 |
2018-05-29 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
US10150818B2
(en)
|
2014-01-16 |
2018-12-11 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
JP2017504651A
(ja)
|
2014-01-31 |
2017-02-09 |
ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド |
ジアゼパン誘導体の使用
|
MX2016011160A
(es)
|
2014-02-28 |
2017-04-27 |
Tensha Therapeutics Inc |
Tratamiento de afecciones asociadas con la hiperinsulinemia.
|
EP3119415A4
(en)
|
2014-03-07 |
2017-11-29 |
The Arizona Board of Regents on behalf of the University of Arizona |
Non-narcotic crmp2 peptides targeting sodium channels for chronic pain
|
PT3119397T
(pt)
|
2014-03-19 |
2022-04-11 |
Infinity Pharmaceuticals Inc |
Compostos heterocíclicos para utilização no tratamento de distúrbios mediados por pi3k-gama
|
EP3129767B1
(en)
|
2014-03-27 |
2021-09-01 |
Academia Sinica |
Reactive labelling compounds and uses thereof
|
US10293035B2
(en)
|
2014-03-28 |
2019-05-21 |
University Of Washington Through Its Center For Commercialization |
Breast and ovarian cancer vaccines
|
WO2015168079A1
(en)
|
2014-04-29 |
2015-11-05 |
Infinity Pharmaceuticals, Inc. |
Pyrimidine or pyridine derivatives useful as pi3k inhibitors
|
US10039816B2
(en)
|
2014-04-30 |
2018-08-07 |
Massachusetts Institute Of Technology |
Siderophore-based immunization against gram-negative bacteria
|
WO2015172686A1
(zh)
*
|
2014-05-14 |
2015-11-19 |
苏州大学张家港工业技术研究院 |
气动蓄能式无针注射器
|
CN106573032B
(zh)
|
2014-05-21 |
2022-03-18 |
哈佛大学的校长及成员们 |
Ras抑制肽和其用途
|
US10118969B2
(en)
|
2014-05-27 |
2018-11-06 |
Academia Sinica |
Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
|
KR20240096599A
(ko)
|
2014-05-27 |
2024-06-26 |
아카데미아 시니카 |
항-cd20 글리코항체 및 이의 용도
|
CA2950423A1
(en)
|
2014-05-27 |
2015-12-03 |
Academia Sinica |
Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
|
CN106661099A
(zh)
|
2014-05-27 |
2017-05-10 |
中央研究院 |
抗her2醣抗体及其用途
|
WO2015184001A1
(en)
|
2014-05-28 |
2015-12-03 |
Academia Sinica |
Anti-tnf-alpha glycoantibodies and uses thereof
|
US11571472B2
(en)
|
2014-06-13 |
2023-02-07 |
Glaxosmithkline Biologicals Sa |
Immunogenic combinations
|
MA40240B1
(fr)
|
2014-06-19 |
2019-03-29 |
Ariad Pharma Inc |
Composés hétéroaryle d'inhibition de la kinase
|
WO2015200425A1
(en)
|
2014-06-27 |
2015-12-30 |
Topokine Therapeutics, Inc. |
Topical dosage regimen
|
US9840479B2
(en)
|
2014-07-02 |
2017-12-12 |
Massachusetts Institute Of Technology |
Polyamine-fatty acid derived lipidoids and uses thereof
|
CN106715458A
(zh)
|
2014-07-18 |
2017-05-24 |
华盛顿大学 |
癌症疫苗组合物及其使用方法
|
WO2016025643A1
(en)
|
2014-08-12 |
2016-02-18 |
Massachusetts Institute Of Technology |
Brush-poly(glycoamidoamine)-lipids and uses thereof
|
KR102422375B1
(ko)
|
2014-09-08 |
2022-07-18 |
아카데미아 시니카 |
당지질을 사용한 인간 iNKT 세포 활성화
|
KR20170058424A
(ko)
|
2014-09-24 |
2017-05-26 |
에일러론 테라퓨틱스 인코포레이티드 |
펩티드모방 거대고리 및 이의 용도
|
SG11201702175YA
(en)
|
2014-09-24 |
2017-04-27 |
Aileron Therapeutics Inc |
Peptidomimetic macrocycles and formulations thereof
|
US9708348B2
(en)
|
2014-10-03 |
2017-07-18 |
Infinity Pharmaceuticals, Inc. |
Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof
|
RS60737B1
(sr)
|
2014-10-21 |
2020-09-30 |
Ariad Pharma Inc |
Kristalni oblici 5-hloro-n4-[-2-(dimetilfosforil)fenil]-n2-{2-metoksi-4-[4-(4-metilpiperazin-1-il)piperidin-1-il]pirimidin-2,4-diamina
|
EP3212654B1
(en)
|
2014-10-27 |
2020-04-08 |
Tensha Therapeutics, Inc. |
Bromodomain inhibitors
|
JP2017533238A
(ja)
|
2014-10-28 |
2017-11-09 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
抗原特異的寛容のための組成物及び方法
|
EP3461904A1
(en)
|
2014-11-10 |
2019-04-03 |
ModernaTX, Inc. |
Alternative nucleic acid molecules containing reduced uracil content and uses thereof
|
US10253045B2
(en)
|
2014-11-26 |
2019-04-09 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of a therapeutic compound and uses thereof
|
WO2016094710A1
(en)
|
2014-12-10 |
2016-06-16 |
Kala Pharmaceuticals, Inc. |
1 -amino-triazolo(1,5-a)pyridine-substituted urea derivative and uses thereof
|
WO2016106326A1
(en)
|
2014-12-23 |
2016-06-30 |
Sloan-Kettering Institute For Cancer Research |
Polymorph of granaticin b
|
US9975965B2
(en)
|
2015-01-16 |
2018-05-22 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
US10495645B2
(en)
|
2015-01-16 |
2019-12-03 |
Academia Sinica |
Cancer markers and methods of use thereof
|
AU2015378564A1
(en)
|
2015-01-24 |
2017-07-13 |
Academia Sinica |
Novel glycan conjugates and methods of use thereof
|
EP3294318A4
(en)
|
2015-03-20 |
2019-04-03 |
Aileron Therapeutics, Inc. |
PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF
|
CN107427521B
(zh)
|
2015-03-27 |
2021-08-03 |
达纳-法伯癌症研究所股份有限公司 |
细胞周期蛋白依赖性激酶的抑制剂
|
MY193444A
(en)
|
2015-03-30 |
2022-10-13 |
Greenlight Biosciences Inc |
Cell-free production of ribonucleic acid
|
AU2016255770A1
(en)
|
2015-04-27 |
2017-11-16 |
University Of Florida Research Foundation, Incorporated |
Metabolically programmed metal chelators and uses thereof
|
WO2016178591A2
(en)
|
2015-05-05 |
2016-11-10 |
Gene Predit, Sa |
Genetic markers and treatment of male obesity
|
PT3310764T
(pt)
|
2015-06-19 |
2023-07-11 |
Massachusetts Inst Technology |
2,5-piperazinadionas substituídas por alquenilo e o seu uso em composições para entregar um agente a um sujeito ou célula
|
US10059741B2
(en)
|
2015-07-01 |
2018-08-28 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
JP2018528217A
(ja)
|
2015-09-10 |
2018-09-27 |
エルロン・セラピューティクス・インコーポレイテッドAileron Therapeutics,Inc. |
Mcl−1のモジュレーターとしてのペプチド模倣大環状分子
|
SI3350157T1
(sl)
|
2015-09-17 |
2022-04-29 |
Modernatx, Inc. |
Sestave za doziranje terapevtskih sredstev v celice
|
CA2998370A1
(en)
|
2015-09-17 |
2017-03-23 |
Moderna Therapeutics, Inc. |
Polynucleotides containing a stabilizing tail region
|
EP3355882A1
(en)
|
2015-10-01 |
2018-08-08 |
Kythera Biopharmaceuticals, Inc. |
Compositions comprising a statin for use in methods of adipolysis
|
GB201518684D0
(en)
|
2015-10-21 |
2015-12-02 |
Glaxosmithkline Biolog Sa |
Vaccine
|
JP7114465B2
(ja)
|
2015-12-22 |
2022-08-08 |
モデルナティエックス インコーポレイテッド |
薬剤の細胞内送達のための化合物および組成物
|
JP2019515876A
(ja)
|
2016-03-08 |
2019-06-13 |
アカデミア シニカAcademia Sinica |
N−グリカンおよびそのアレイのモジュール合成のための方法
|
WO2017161116A1
(en)
|
2016-03-17 |
2017-09-21 |
Infinity Pharmaceuticals, Inc. |
Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors
|
SG11201808721YA
(en)
|
2016-04-06 |
2018-11-29 |
Greenlight Biosciences Inc |
Cell-free production of ribonucleic acid
|
IL312520A
(en)
|
2016-06-03 |
2024-07-01 |
Sanofi Pasteur Inc |
Modification of transgenic influenza hemagglutinin polypeptides
|
WO2017214337A1
(en)
|
2016-06-07 |
2017-12-14 |
Massachusetts Institute Of Technology |
Drug delivery polymers and uses thereof
|
US10919914B2
(en)
|
2016-06-08 |
2021-02-16 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
US10549044B2
(en)
|
2016-06-09 |
2020-02-04 |
Becton, Dickinson And Company |
Spacer assembly for drug delivery system
|
US10751476B2
(en)
|
2016-06-09 |
2020-08-25 |
Becton, Dickinson And Company |
Actuator assembly for drug delivery system
|
US10603445B2
(en)
|
2016-06-09 |
2020-03-31 |
Becton, Dickinson And Company |
Needle actuator assembly for drug delivery system
|
US10792432B2
(en)
|
2016-06-09 |
2020-10-06 |
Becton, Dickinson And Company |
Drive assembly and spacer for drug delivery system
|
WO2017218704A1
(en)
|
2016-06-14 |
2017-12-21 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
GB201610599D0
(en)
|
2016-06-17 |
2016-08-03 |
Glaxosmithkline Biologicals Sa |
Immunogenic Composition
|
JP7001687B2
(ja)
|
2016-08-05 |
2022-02-04 |
サノフィ パスツール インコーポレイティッド |
多価肺炎球菌多糖体-タンパク質コンジュゲート組成物
|
JP7001686B2
(ja)
|
2016-08-05 |
2022-02-04 |
サノフィ パスツール インコーポレイティッド |
多価肺炎球菌多糖体-タンパク質コンジュゲート組成物
|
CA3034057A1
(en)
|
2016-08-22 |
2018-03-01 |
CHO Pharma Inc. |
Antibodies, binding fragments, and methods of use
|
WO2018089540A1
(en)
|
2016-11-08 |
2018-05-17 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
WO2018106738A1
(en)
|
2016-12-05 |
2018-06-14 |
Massachusetts Institute Of Technology |
Brush-arm star polymers, conjugates and particles, and uses thereof
|
JP7332478B2
(ja)
|
2017-03-15 |
2023-08-23 |
モデルナティエックス インコーポレイテッド |
脂質ナノ粒子製剤
|
EP4186888A1
(en)
|
2017-03-15 |
2023-05-31 |
ModernaTX, Inc. |
Compound and compositions for intracellular delivery of therapeutic agents
|
EP3601326A4
(en)
|
2017-03-20 |
2020-12-16 |
The Broad Institute, Inc. |
COMPOUNDS AND METHODS OF REGULATING INSULIN SECRETION
|
US12077501B2
(en)
|
2017-06-14 |
2024-09-03 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of agents
|
EP3641828B1
(en)
|
2017-06-23 |
2023-11-22 |
Affinivax, Inc. |
Immunogenic compositions
|
WO2019013789A1
(en)
|
2017-07-12 |
2019-01-17 |
Curza Global, Llc |
ANTIMICROBIAL COMPOUNDS
|
WO2019013790A1
(en)
|
2017-07-12 |
2019-01-17 |
Curza Global, Llc |
ANTIMICROBIAL COMPOUNDS AND USES THEREOF
|
WO2019046809A1
(en)
|
2017-08-31 |
2019-03-07 |
Modernatx, Inc. |
METHODS OF MANUFACTURING LIPID NANOPARTICLES
|
AR113764A1
(es)
|
2017-10-11 |
2020-06-10 |
Greenlight Biosciences Inc |
Métodos y composiciones para la producción de nucleósido trifosfato y ácido ribonucleico
|
EP4397336A2
(en)
|
2017-10-16 |
2024-07-10 |
Becton, Dickinson and Company |
Spacer assembly for drug delivery device
|
WO2019109079A1
(en)
|
2017-12-01 |
2019-06-06 |
North Carolina State University |
Fibrin particles and methods of making the same
|
GB201721582D0
(en)
|
2017-12-21 |
2018-02-07 |
Glaxosmithkline Biologicals Sa |
S aureus antigens and immunogenic compositions
|
GB201721576D0
(en)
|
2017-12-21 |
2018-02-07 |
Glaxosmithkline Biologicals Sa |
Hla antigens and glycoconjugates thereof
|
EP3853202A1
(en)
|
2018-09-19 |
2021-07-28 |
ModernaTX, Inc. |
Compounds and compositions for intracellular delivery of therapeutic agents
|
US12090235B2
(en)
|
2018-09-20 |
2024-09-17 |
Modernatx, Inc. |
Preparation of lipid nanoparticles and methods of administration thereof
|
JP2022518230A
(ja)
|
2019-01-16 |
2022-03-14 |
カーザ グローバル, エルエルシー |
抗菌化合物及び方法
|
CN113924292A
(zh)
|
2019-01-16 |
2022-01-11 |
库扎环球有限责任公司 |
抗微生物化合物和方法
|
DE102019200563A1
(de)
*
|
2019-01-17 |
2020-07-23 |
Lts Lohmann Therapie-Systeme Ag |
Applikator
|
CA3128215A1
(en)
|
2019-01-31 |
2020-08-06 |
Modernatx, Inc. |
Methods of preparing lipid nanoparticles
|
WO2020168466A1
(en)
|
2019-02-19 |
2020-08-27 |
Stemirna Therapeutics Co., Ltd. |
Modified nucleoside and synthetic methods thereof
|
EP4003410A1
(en)
|
2019-07-31 |
2022-06-01 |
Sanofi Pasteur, Inc. |
Multivalent pneumococcal polysaccharide-protein conjugate compositions and methods of using the same
|
AU2020319876A1
(en)
|
2019-07-31 |
2022-02-24 |
Modernatx, Inc. |
Compositions and methods for delivery of RNA interference agents to immune cells
|
US20230278987A1
(en)
|
2019-11-13 |
2023-09-07 |
Curza Global, Llc |
Antimicrobial Compounds and Methods
|
IL294866A
(en)
|
2020-01-31 |
2022-09-01 |
Modernatx Inc |
Methods for preparing fat nanoparticles
|
US11642407B2
(en)
|
2020-02-28 |
2023-05-09 |
Massachusetts Institute Of Technology |
Identification of variable influenza residues and uses thereof
|
WO2021231729A1
(en)
|
2020-05-13 |
2021-11-18 |
Sanofi |
Adjuvanted stabilized stem hemagglutinin nanoparticles and methods of using the same to induce broadly neutralizing antibodies against influenza
|
CN117083065A
(zh)
|
2020-10-30 |
2023-11-17 |
庆应义塾 |
肌肉减少症相关疾病等的新颖治疗和预防
|
EP4238979A4
(en)
|
2020-10-30 |
2024-09-25 |
Xeno Interface Inc |
CROSS-LINKED BETA-STRAND PEPTIDE
|
TW202237068A
(zh)
|
2020-12-09 |
2022-10-01 |
美商建南德克公司 |
製備脂質奈米顆粒的高通量方法及其用途
|
WO2022146931A1
(en)
*
|
2021-01-03 |
2022-07-07 |
Fpin Llc |
Damped autoinjectors
|
EP4305088A1
(en)
|
2021-03-09 |
2024-01-17 |
Massachusetts Institute of Technology |
Branched poly(-amino esters) for the delivery of nucleic acids
|
TW202313065A
(zh)
|
2021-05-28 |
2023-04-01 |
美商季卡尼醫療公司 |
用於治療遺傳疾病之化合物
|
EP4384534A1
(en)
|
2021-08-11 |
2024-06-19 |
Sanofi Pasteur, Inc. |
Truncated influenza neuraminidase and methods of using the same
|
WO2023039108A1
(en)
|
2021-09-08 |
2023-03-16 |
Affinivax, Inc. |
Coronavirus vaccine
|
WO2023059857A1
(en)
|
2021-10-08 |
2023-04-13 |
Sanofi Pasteur Inc. |
Multivalent influenza vaccines
|
WO2023079113A1
(en)
|
2021-11-05 |
2023-05-11 |
Sanofi |
Hybrid multivalent influenza vaccines comprising hemagglutinin and neuraminidase and methods of using the same
|
KR20240105412A
(ko)
|
2021-11-05 |
2024-07-05 |
사노피 파스퇴르 인크 |
재조합 헤마글루티닌과 뉴라미니다제를 포함하는 다가 인플루엔자 백신 및 이의 사용 방법
|
WO2023114889A1
(en)
|
2021-12-16 |
2023-06-22 |
Modernatx, Inc. |
Processes for preparing lipid nanoparticles
|
WO2023129963A1
(en)
|
2021-12-30 |
2023-07-06 |
Curza Global, Llc |
Antimicrobial compounds and methods
|
WO2023145735A1
(ja)
|
2022-01-25 |
2023-08-03 |
元詞 早野 |
サルコペニアを含む老化関連異常の抑制の新規治療と予防
|
WO2023144206A1
(en)
|
2022-01-27 |
2023-08-03 |
Sanofi Pasteur |
Modified vero cells and methods of using the same for virus production
|
WO2023177579A1
(en)
|
2022-03-14 |
2023-09-21 |
Sanofi Pasteur Inc. |
Machine-learning techniques in protein design for vaccine generation
|
WO2023193002A1
(en)
|
2022-04-01 |
2023-10-05 |
Modernatx, Inc. |
Cross mixers for lipid nanoparticle production, and methods of operating the same
|
WO2023235380A1
(en)
|
2022-06-01 |
2023-12-07 |
Zikani Therapeutics, Inc. |
Macrolides for treating genetic diseases
|
WO2023250513A1
(en)
|
2022-06-24 |
2023-12-28 |
Zikani Therapeutics, Inc. |
13-membered macrolide compounds for treating diseases mediated by abnormal protein translation
|
WO2024026482A1
(en)
|
2022-07-29 |
2024-02-01 |
Modernatx, Inc. |
Lipid nanoparticle compositions comprising surface lipid derivatives and related uses
|
WO2024026487A1
(en)
|
2022-07-29 |
2024-02-01 |
Modernatx, Inc. |
Lipid nanoparticle compositions comprising phospholipid derivatives and related uses
|
WO2024026475A1
(en)
|
2022-07-29 |
2024-02-01 |
Modernatx, Inc. |
Compositions for delivery to hematopoietic stem and progenitor cells (hspcs) and related uses
|
WO2024049994A1
(en)
|
2022-09-01 |
2024-03-07 |
Zikani Therapeutics, Inc. |
Treatment of familial adenomatous polyopsis using a 13-membered macrolide
|
WO2024091918A2
(en)
|
2022-10-25 |
2024-05-02 |
Modernatx, Inc. |
Methods of lipid nanoparticle production in cross-mixers
|
WO2024121380A1
(en)
|
2022-12-08 |
2024-06-13 |
Pierre Fabre Medicament |
Vaccinal composition and adjuvant
|